KEMH Takes Part In Hip Replacement Innovation
February 17, 2025 https://bernews.com/2025/02/kemh-pioneers-hip-replacement-innovation/
King Edward VII Memorial Hospital is participating in an FDA clinical study for the Polymotion Hip Resurfacing implant, making it the first overseas center to contribute to this groundbreaking research.
A spokesperson said, “Bermuda Hospitals Board [BHB] is part of a US Food and Drug Administration [FDA] clinical study to bring a new orthopaedic implant to the United States. The Polymotion Hip Resurfacing [PHRTM] is a new hip replacement device that will be used in men and women under age 65 as a part of the clinical study. In time, Polymotion may join its predecessor, the Birmingham Hip Resurfacing [BHRTM], as a globally available hip resurfacing device…
…“Orthopaedic surgeon Dr Ronan Treacy is a co-inventor of Polymotion. He also designed the Birmingham implant in the late 1990s. He’s been a regular visiting surgeon in Bermuda for over 25 years and has performed hundreds of Birmingham Hip Resurfacing procedures on local residents at King Edward VII Memorial Hospital [KEMH]…
Tim Band, Senior Director Maket Development, JointMedica; Dr William Peckett, BHB Director of Orthopaedics; dr Sharat Kusuma, President, JointMedica; Jason Osier and Warner Watkins distribution agents, JointMedica
“Over 200 patients are expected to be enrolled in the study, which will run for at least 2 years. We would be expecting to enroll approximately 20 Bermudian patients in total over that time period.”